Use of financial incentives to increase adult vaccination coverage: A narrative review of lessons learned from COVID-19 and other adult vaccination efforts

Schwalbe, Nina; Hanbali, Layth; Nunes, Marta C.; Lehtimaki, Susanna

doi:10.1016/j.jvacx.2022.100225

Cited by 16 publications

(7 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These measures ranged from suggesting restricted social interactions, extra protection, and care in hospitals to being identi ed as the rst group to receive the COVID-19 vaccine in India on the 16th of January 2021 (28). An emphasis on routine adult vaccination was also suggested for other infectious diseases (29,30). The overhauled health system during the COVID-19 pandemic, like the added laboratory facilities and increased hospital and ICU beds, and the sensitised health providers provided a signi cant change in chronic illness and multimorbidity care and a relook at the government programs for NCDs.…”

Section: Discussionmentioning

confidence: 99%

Managing multiple long-term conditions or multimorbidity across COVID-19 pandemic: a longitudinal qualitative study from India

Mahapatra,

Sahoo,

Pati

2023

Preprint

View full text Add to dashboard Cite

Objectives While many studies have documented adverse impact of multiple chronic conditions or multimorbidity on COVID-19 outcomes in patients, there is scarcity of report on how physicians managed these patients. We investigated the experiences and challenges of clinicians in managing patients with multimorbidity throughout the COVID-19 pandemic in Odisha state, India. Methods To understand the factors influencing illness management and the adaptive responses of physicians alongside the evolving pandemic, we followed a longitudinal qualitative study design. Twenty-three physicians comprising general practitioners, specialists, and intensivists, were telephonically interviewed in-depth. Saldana’s longitudinal qualitative data analysis method was employed for data analysis. Results COVID-19 pandemic initially diverted the attention of health systems, resulting in reduced care. With time, the physicians overcame fear, anxiety, and feelings of vulnerability to COVID-19 and started prioritising patients with multimorbidity for treatment and vaccination. All physicians recommended teleconsultation and digital health records to benefit chronic illness care during future public health crises Conclusion As the COVID-19 pandemic progressed, the importance of multiple long-term conditions was given increasingly importance by physicians underscoring the need to address them perennially. They became gradually resilient with the pandemic and paced with the changing health system to ensure care continuity for patients with multimorbidity.

show abstract

Section: Discussionmentioning

confidence: 99%

Managing multiple long-term conditions or multimorbidity across COVID-19 pandemic: a longitudinal qualitative study from India

Mahapatra,

Sahoo,

Pati

2023

Preprint

View full text Add to dashboard Cite

show abstract

“…For example, monetary incentives seem to raise vaccination likelihood for those who are reluctant to be vaccinated but not for the unwilling [ 67 ]. Meta-analyses find the study effect sizes to be small or non-existent [ 68 , 69 ].…”

Section: Literaturementioning

confidence: 99%

How Scientists View Vaccine Hesitancy

et al. 2023

View full text Add to dashboard Cite

This paper examines possible causes, consequences, and potential solutions for addressing vaccine hesitancy in the United States, focusing on the perspectives of academic scientists. By examining the experiences of scientists, who are arguably a critical community in US society, we gain deeper insights into how they understand the complexities of vaccine hesitancy and whether their insights and opinions converge with or diverge from the current literature. We present findings from a national survey of a representative sample of academic scientists from the fields of biology and public health regarding vaccine hesitancy and related topics. Empirical analysis using descriptive, bivariate, and multivariate analyses covers multiple topics, including vaccine controversy, trust in science, causes of vaccine hesitancy, preferred policy and regulatory approaches, risk perceptions, and scientists’ ethics and perceived communication roles. The results highlight a diversity of opinions within the scientific community regarding how to improve science-society communication in regard to vaccines, including the need to be transparent and candid to the public about the risk of vaccines and their research.

show abstract

“…Financial incentives increase the immediate benefits of vaccination and can mitigate perceived costs of and barriers to vaccination, including hesitancy related to vaccine safety and hassle factors associated with accessing vaccination services. 7 Evidence on the effectiveness of incentives for COVID-19 vaccination comes almost exclusively from high-income countries and is mixed [8][9][10][11][12][13][14][15] : some studies found that guaranteed rewards can increase vaccination, 8 9 while others showed no effect of guaranteed or lottery incentives, 10 16 17 or indicated that incentives may backfire by decreasing vaccination intentions. 11 Low and middle-income countries (LMICs) have faced a substantial burden of COVID-19, but there is lack of evidence on whether incentives for COVID-19 are effective in LMICs.…”

Section: What Does This Study Addmentioning

confidence: 99%

Quasi-experimental evaluation of a financial incentive for first-dose COVID-19 vaccination among adults aged ≥60 years in South Africa

et al. 2022

View full text Add to dashboard Cite

IntroductionCOVID-19 vaccination coverage in South Africa (RSA) remains low despite increased access to vaccines. On 1 November 2021, RSA introduced the Vooma Voucher programme which provided a small guaranteed financial incentive, a Vooma Voucher redeemable at grocery stores, for COVID-19 vaccination among older adults, a population most vulnerable to serious illness, hospitalisation and death. However, the association of financial incentives with vaccination coverage remains unclear.MethodsWe evaluated the association of the conditional economic incentive programme with first-dose vaccination rates among adults (aged ≥60 years) through a quasi-experimental cohort study. The Vooma Voucher programme was a nationwide vaccination incentive programme implemented for adults aged ≥60 years from 1 November 2021 to 28 February 2022. We ran ITS models to evaluate the Vooma Voucher programme at national and provincial levels. We used data between 1 October 2021 and 27 November 2021 in models estimated at the daily level. Individuals who received their first vaccine dose received a text message to access a ZAR100 ($~7) voucher that was redeemable at grocery stores.ResultsThe Vooma Voucher programme was associated with a 7.15%–12.01% increase in daily first-dose vaccinations in November 2021 compared with late October 2021. Overall, the incentive accounted for 6476–10 874 additional first vaccine doses from 1 November to 27 November 2021, or 8.31%–13.95% of all doses administered to those aged ≥60 years during that period. This result is robust to the inclusion of controls for the number of active vaccine delivery sites and for the nationwide Vooma vaccination weekend initiative (12 November to 14 November), both of which also increased vaccinations through expanded access to vaccines and demand creation activities.ConclusionsFinancial incentives for COVID-19 vaccination led to a modest increase in first-dose vaccinations among older adults in RSA. Financial incentives and expanded access to vaccines may result in higher vaccination coverage.Trial registration number (SANCTR)DOH-27-012022-9116.

show abstract

Use of financial incentives to increase adult vaccination coverage: A narrative review of lessons learned from COVID-19 and other adult vaccination efforts

Cited by 16 publications

References 47 publications

Managing multiple long-term conditions or multimorbidity across COVID-19 pandemic: a longitudinal qualitative study from India

Managing multiple long-term conditions or multimorbidity across COVID-19 pandemic: a longitudinal qualitative study from India

How Scientists View Vaccine Hesitancy

Quasi-experimental evaluation of a financial incentive for first-dose COVID-19 vaccination among adults aged ≥60 years in South Africa

Contact Info

Product

Resources

About